Free Anti-Vedolizumab

Free Anti-Vedolizumab
Detecting the development of Anti-drug antibodies (ADAs) against Vedolizumab in patients being treated with Vedolizumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Vedolizumab can detect the presence of anti-drug antibodies against Vedolizumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum
• Reaction Time 10 mins
  
• Detection Range 10~250 ng/mL
  
• Indication Quantitative determination of free antibodies against Vedolizumab including in human whole blood/serum.
  

Click